Automated Enrichment, Transduction, and Expansion of Clinical-Scale CD62L+ T Cells for Manufacturing of Gene Therapy Medicinal Products-Reference-Cited by-同舟云学术

Automated Enrichment, Transduction, and Expansion of Clinical-Scale CD62L+ T Cells for Manufacturing of Gene Therapy Medicinal Products

Published:2016-10 Issue:10 Volume:27 Page:860-869
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Priesner Christoph¹,Aleksandrova Krasimira¹,Esser Ruth²,Mockel-Tenbrinck Nadine³,Leise Jana¹,Drechsel Katharina³,Marburger Michael²,Quaiser Andrea²,Goudeva Lilia⁴,Arseniev Lubomir¹,Kaiser Andrew D.³,Glienke Wolfgang²,Koehl Ulrike¹²

Affiliation:

1. Cellular Therapy Center, Institute of Cellular Therapeutics, Hannover Medical School, Hannover, Germany

2. GMP Development Unit, Institute of Cellular Therapeutics, Integrated Research and Treatment Center for Transplantation, Hannover Medical School, Hannover, Germany

3. Miltenyi Biotec, Bergisch Gladbach, Germany.

4. Institute of Transfusion Medicine, Hannover Medical School, Hannover, Germany

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2016.091

Reference28 articles.

1. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

2. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

3. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia